NIM
ONC

NEOS Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

NEOS Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,187
Closed -$2.49M – 664
2025
Q4 		$2.49M Buy
8,187
+1,416
+21% +$463K 0.01% 444
2025
Q3 		$2.31M Sell
6,771
-936
-12% -$284K 0.02% 422
2025
Q2 		$1.87M Buy
7,707
+624
+9% +$153K 0.02% 383
2025
Q1 		$1.93M Buy
7,083
+834
+13% +$195K 0.04% 328
2024
Q4 		$1.15M Sell
6,249
-189
-3% -$38.6K 0.03% 379
2024
Q3 		$1.45M Buy
6,438
+407
+7% +$73.2K 0.04% 316
2024
Q2 		$860K Buy
6,031
+3,515
+140% +$542K 0.04% 356
2024
Q1 		$393K Buy
2,516
+74
+3% +$11.9K 0.02% 443
2023
Q4 		$440K Buy
+2,442
New +$442K 0.04% 309

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return